The story begins with a shared vision and a deep-seated passion for improving lives through clinical trials. Dr. Joel S. Ross, MD, (NPI Number 1306982392), a leading figure in Alzheimer's disease research, was making groundbreaking strides at the Memory Enhancement Center of America in Long Branch, New Jersey. With an illustrious career spanning over two decades, Dr. Joel S. Ross has been at the forefront of Alzheimer's disease research, serving as a Principal Investigator or Sub-investigator on nearly every Alzheimer's disease drug in clinical trials. His expertise and dedication to advancing Alzheimer's treatment options were further exemplified by his leadership in over 100 Alzheimer's disease research protocols as a Principal Investigator, successfully meeting FDA guidelines and protocol requirements.

​

Dr. Ross is the Founder, CEO, Primary Care Geriatrician, and Principal Investigator at the Memory Enhancement Center of America in Long Branch, New Jersey. Dr. Ross served as Principal Investigator or Sub-investigator on nearly every Alzheimer’s disease drug in clinical trials since 1994, including Ondansetron, Cognex, Donepezil, Exelon, Memantine, and, most recently, Alzhemed (Neurochem) and ELN116727 (ELAN). He has several hospital appointments and Medical Directorships in the state of New Jersey. Dr. Ross received his undergraduate degree from Hofstra and his M.D. from Downstate Medical Center, Brooklyn, New York. He completed his internship and residency at Nassau County Medical Center in East Meadow, New York, where he then became chief resident. He is certified in Geriatric Medicine and Internal Medicine by the National Board of Medical Examiners.

​

Dr Ross has held leadership roles in over 100 clinical trial studies overseen by the U.S. Food, Drug Administration (FDA), Clinicaltrials.gov, and NIH. This experience includes pivotal trials that led to the FDA approval of numerous landmark medications.

​

Simultaneously, on the country's southern side, Dr. Max Arocha, DMD (NPI 179083016), is a licensed medical professional and medical staff member at Memorial Regional Hospital and Holy Cross Health. He completed his postdoctoral residency at Lehigh Valley Hospital. He holds multiple U.S and International patents, leads FDA-cleared innovations, and is committed to advancing patient care through clinical trials 

 

Dr Arocha is a successful entrepreneur and innovator with a proven track record in establishing thriving private practices in South Florida and the successful development of a Florida-based pharmaceutical and biotechnology company (PharmaPhD).

 

The paths of these two visionary leaders crossed through a shared commitment to advancing healthcare and a mutual recognition of the need for innovative solutions to address the growing challenges of clinical trial patient recruitment and retention. Dr. Arocha's entrepreneurial acumen and Dr. Ross's unparalleled expertise in Alzheimer's disease research formed a powerful synergy, laying the foundation for a groundbreaking collaboration that formed the world's largest clinical trial patient dataset.

 

 

Adding to this dynamic duo was Debra L. Ross, Esq, an experienced attorney who transitioned into the executive director role at the Memory Enhancement Centers. Debra's sharp legal mind and her certification as a Clinical Research Coordinator (CCRC) accredited by the Association of Clinical Research Professionals (ACRP) brought a critical dimension to the team. Her meticulous oversight of staff, data management, and quality assurance ensured the highest standards of clinical research were met.

​

This formidable team, along with a dedicated network of colleagues and family members, including Dr. Max Arocha, his wife Dr. Karla Jaquez, and their extended family of medical professionals, embarked on a mission to revolutionize clinical trial care. Their unwavering commitment to the highest standards of clinical trial sites and research, combined with their diverse expertise and shared passion, ignited a spark that would soon transform the landscape of clinical trial patient recruitment and retention.